Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab

Update Il y a 4 ans
Reference: NCT00307931

Woman and Man

  • | Country :
  • Greece
  • | organs :
  • -
  • | Specialty :
  • -

Extract

An open-label multi-center single-cohort study to assess the safety and efficacy of certolizumab pegol for the treatment of signs and symptoms of active Crohn's disease in Greek patients who have previously responded to infliximab but who no longer have a sustained response or became intolerant to infliximab


Inclusion criteria

  • Crohn’s Disease

Links